The Board of Directors authorized a third-quarter stock dividend payable in common shares to holders of Series B Preferred Stock. The payout is calculated by dividing accrued and unpaid dividends by $2.38, resulting in approximately 81,339 new common shares. Fractional shares will be settled in cash. The distribution is payable on October 30, 2026, to record holders as of October 26, 2026. Neuraxis operates in the medical device industry.
